Results 171 to 180 of about 5,803 (182)

Pharmacokinetics, Safety, and Tolerability of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in Healthy Chinese Subjects

Clinical Therapeutics, 2020
Xiaojiao Li, Yanhua Ding, Hong Zhang
exaly  

Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study

Journal of Hepatology, 2017
Zu-Jiang Yu, Qing-Lei Zeng
exaly  

A new innovative spectrophotometric method for the simultaneous determination of sofosbuvir and ledipasvir

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2018
Fotouh Mansour
exaly  

A Thorough QT Study to Evaluate the Effects of Supratherapeutic Doses of Ledipasvir on the QTc Interval in Healthy Subjects

Clinical Pharmacology in Drug Development, 2018
Polina German
exaly  

Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4

Cells, 2019
Carlo Torti, Maria Carla Liberto, Enrico Trecarichi   +2 more
exaly  

Study on the forced degradation behaviour of ledipasvir: Identification of major degradation products using LC–QTOF–MS/MS and NMR

Journal of Pharmaceutical and Biomedical Analysis, 2017
Gananadhamu Samanthula, Debasish Swain
exaly  

Chromatographic analysis of ledipasvir and sofosbuvir: New treatment for chronic hepatitis C infection with application to human plasma

Journal of Liquid Chromatography and Related Technologies, 2017
Nehal Farid, Nada Abdelwahab
exaly  

Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan

Journal of Medical Virology, 2017
Norio Akuta, Yusuke Kawamura, Tetsuya Hosaka   +2 more
exaly  

Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC–MS/MS and its application to a pharmacokinetic study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2016
Yong-Ping Chen
exaly  

Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection

Gastroenterology, 2014
Catherine Stedman, Robert Hyland, Edward Gane   +2 more
exaly